The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study
C. Queille-Roussel, C. Paul, L. Duteil, M-C. Lefebvre, G. Rapatz, M. Zagula, J-P. OrtonneVolume:
144
Year:
2001
Language:
english
Pages:
7
DOI:
10.1046/j.1365-2133.2001.04076.x
File:
PDF, 515 KB
english, 2001